← Leaderboards
Yasmin Thanavala
Roswell Park Cancer Institute Corp
$4,506,996
Attributed
$6,230,322
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,230,322 · 6
By mechanism
R01$3,637,068 · 2
R44$1,275,809 · 1
R56$890,369 · 1
R21$427,076 · 1
P01$0 · 1
Top collaborators
- Maciej Lukasz Goniewicz3 shared
- Robert G. Britt2 shared
- Renuka Iyer2 shared
- Hugh Mason2 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Pawel Kalinski$15,491,276
- Christine B. Ambrosone$40,409,261
- Destiny Diaz$364,059
- Maciej Lukasz Goniewicz$7,908,117
- Nicholas John Felicione$469,024
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseInfectionPathogenResponseImmunityLungInflammationInflammatoryBacterial InfectionsHaemophilus InfluenzaeChronicRespiratoryVaccinesDesignVaccine DevelopmentCytokineVaccinationImmuneResolutionExposure ToCellsLung DiseasesBaseMarketing
Grant awards (17)
Impact of novel Heat-not-Burn cigarettes on pulmonary inflammation and immunity$497,698
R01 · FY2021 · HL · contact PI
Impact of novel Heat-not-Burn cigarettes on pulmonary inflammation and immunity$511,141
R01 · FY2020 · HL · contact PI
Impact of novel Heat-not-Burn cigarettes on pulmonary inflammation and immunity$524,100
R01 · FY2019 · HL · contact PI
Innate and adaptive immune responses at the respiratory mucosa$227,162
R21 · FY2010 · AI · contact PI
Plant-Derived hepatitis B Vaccine from Biomanufacturing System to Clinical Trial$642,697
R44 · FY2009 · HL
Innate and adaptive immune response to bacterial infections in COPD patients$491,634
R56 · FY2009 · AI · contact PI
Innate and adaptive immune responses at the respiratory mucosa$199,914
R21 · FY2009 · AI · contact PI
Plant-Derived hepatitis B Vaccine from Biomanufacturing System to Clinical Trial$633,112
R44 · FY2008 · HL
Innate and adaptive immune response to bacterial infections in COPD patients$398,735
R56 · FY2008 · AI · contact PI
Hepatitis B Subunit Oral Vaccine in Transgenic Plants$368,597
R01 · FY2007 · AI · contact PI
Hepatitis B Subunit Oral Vaccine in Transgenic Plants$368,550
R01 · FY2006 · AI · contact PI
Hepatitis B Subunit Oral Vaccine in Transgenic Plants$366,427
R01 · FY2005 · AI
Hepatitis B Subunit Oral Vaccine in Transgenic Plants$355,755
R01 · FY2004 · AI
Hepatitis B Subunit Oral Vaccine in Transgenic Plants$344,785
R01 · FY2003 · AI
Immunity to Epitopes of the P6 Protein of H. influenzae$0
P01 · FY2002 · AI
Immunity to Epitopes of the P6 Protein of H. influenzae$0
P01 · FY2001 · AI
HEPATITIS B SUBUNIT ORAL VACCINE IN TRANSGENIC PLANTS$300,015
R01 · FY2000 · AI